The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial

University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville 32610-0277.

OBJECTIVES. The primary objectives of the Asymptomatic Cardiac Ischemia Pilot were 1) to compare the 12-week efficacy of three treatment strategies to suppress cardiac ischemia, and 2) to assess the feasibility of a prognosis trial in patients with asymptomatic cardiac ischemia. BACKGROUND. Cardiac ischemia has been associated with increased morbidity and mortality. However, most cardiac ischemia is asymptomatic, and although therapeutic strategies ranging from no medication to revascularization are being used to treat ischemia, no prospective study evaluating different treatment strategies has been reported. METHODS. Patients with angiographically documented coronary artery disease and ischemia on exercise and ambulatory electrocardiogram (ECG) in 11 clinical units were randomized to receive angina-guided medical therapy, angina-guided plus ambulatory ECG ischemia-guided medical therapy or revascularization (coronary angioplasty or bypass surgery). Patients were also randomized to receive either diltiazem plus isosorbide dinitrate or atenolol plus nifedipine when possible. After anti-ischemic medication adjustment to control angina, blinded medication was adjusted in the medical therapy groups to eliminate ischemia in the ischemia-guided group. The primary outcome was the absence of ischemia at 12 weeks. Follow-up was scheduled for 1 year. RESULTS. A total of 1,959 patients were screened by ambulatory ECG monitoring; 982 (49%) had asymptomatic ischemia, and 618 (65%) were enrolled in the study. Most patients were men, were > 60 years old and had two or more ischemic episodes, early positive exercise tests and multivessel disease. CONCLUSIONS. Design and baseline data for a pilot study of ischemia treatment strategies are described.

This article has been cited by other articles:

				J. W. Hughes, K. M. York, Q. Li, K. E. Freedland, R. M. Carney, and D. S. Sheps Depressive Symptoms Predict Heart Rate Recovery After Exercise Treadmill Testing in Patients With Coronary Artery Disease: Results From the Psychophysiological Investigations of Myocardial Ischemia Study Psychosom Med, May 1, 2008; 70(4): 456 - 460. [Abstract] [Full Text] [PDF]

				M. L. Brown, T. M. Sundt III, and B. J. Gersh Indications for Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572. [Full Text]

				J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]

				P. Erne, A. W. Schoenenberger, D. Burckhardt, M. Zuber, W. Kiowski, P. T. Buser, P. Dubach, T. J. Resink, and M. Pfisterer Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial JAMA, May 9, 2007; 297(18): 1985 - 1991. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF]

				N. L Geller, P. Sorlie, S. Coady, J. Fleg, and L. Friedman Limited access data sets from studies funded by the National Heart, Lung, and Blood Institute Clinical Trials, December 1, 2004; 1(6): 517 - 524. [Abstract] [PDF]

				W. Hueb, P. R. Soares, B. J. Gersh, L. A. M. Cesar, P. L. Luz, L. B. Puig, E. M. Martinez, S. A. Oliveira, and J. A. F. Ramires The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: One-year results J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1743 - 1751. [Abstract] [Full Text] [PDF]

				C. J. Pepine, J.-L. Rouleau, K. Annis, A. Ducharme, P. Ma, J. Lenis, R. Davies, U. Thadani, B. Chaitman, H. E. Haber, et al. Effects of angiotensin-converting enzyme inhibition on transient ischemia: The quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2049 - 2059. [Abstract] [Full Text] [PDF]

				T. M. Sundt III, B. J. Gersh, and H. C. Smith Indications for Coronary Revascularization Card. Surg. Adult, January 1, 2003; 2(2003): 541 - 559. [Full Text]

				N. Gokce, M. Holbrook, L. M. Hunter, J. Palmisano, E. Vigalok, J. F. Keaney Jr, and J. A. Vita Acute effects of vasoactive drug treatment on brachial artery reactivity J. Am. Coll. Cardiol., August 21, 2002; 40(4): 761 - 765. [Abstract] [Full Text] [PDF]

				The IONA Study Group Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management Heart, June 1, 2001; 85(6): 9e - 9. [Abstract] [Full Text]

				E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) J. Am. Coll. Cardiol., September 1, 2000; 36(3): 970 - 1062. [Full Text] [PDF]

				P. N. Ruygrok, R. Melkert, M.-A. M. Morel, J. A. Ormiston, F. W. Bar, F. Fernandez-Aviles, H. Suryapranata, K. D. Dawkins, C. Hanet, P. W. Serruys, et al. Does angiography six months after coronary intervention influence management and outcome? J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1507 - 1511. [Abstract] [Full Text] [PDF]

				C. N. Bairey Merz, S. F. Kelsey, C. J. Pepine, N. Reichek, S. E. Reis, W. J. Rogers, B. L. Sharaf, G. Sopko, and for the WISE Study Group The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1453 - 1461. [Abstract] [Full Text] [PDF]

				P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1756 - 1824. [Full Text] [PDF]

				R. G. Favaloro Landmarks in the Development of Coronary Artery Bypass Surgery Circulation, August 4, 1998; 98(5): 466 - 478. [Full Text] [PDF]

				K. Takano, R.A.D. Carano, T. Tatlisumak, M. Meiler, C. H. Sotak, H. D. Kleinert, and M. Fisher Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging Neurology, April 1, 1998; 50(4): 870 - 875. [Abstract] [Full Text] [PDF]

				R. F. Davies, A. D. Goldberg, S. Forman, C. J. Pepine, G. L. Knatterud, N. Geller, G. Sopko, C. Pratt, J. Deanfield, and C. R. Conti Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up : Outcomes of Patients Randomized to Initial Strategies of Medical Therapy Versus Revascularization Circulation, April 15, 1997; 95(8): 2037 - 2043. [Abstract] [Full Text]

				P. H. Stone, B. R. Chaitman, R. P. McMahon, T. C. Andrews, G. MacCallum, B. Sharaf, W. Frishman, J. E. Deanfield, G. Sopko, C. Pratt, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: Relationship Between Exercise-Induced and Ambulatory Ischemia in Patients With Stable Coronary Disease Circulation, October 1, 1996; 94(7): 1537 - 1544. [Abstract] [Full Text]

				E. A. Caracciolo, B. R. Chaitman, S. A. Forman, P. H. Stone, M. G. Bourassa, G. Sopko, N. L. Geller, and C. R. Conti Diabetics With Coronary Disease Have a Prevalence of Asymptomatic Ischemia During Exercise Treadmill Testing and Ambulatory Ischemia Monitoring Similar to That of Nondiabetic Patients : An ACIP Database Study Circulation, June 15, 1996; 93(12): 2097 - 2105. [Abstract] [Full Text]

				C. J. Pepine Prognostic Implications of Silent Myocardial Ischemia N. Engl. J. Med., January 11, 1996; 334(2): 113 - 114. [Full Text]

				M. G. Bourassa, G. L. Knatterud, C. J. Pepine, G. Sopko, W. J. Rogers, N. L. Geller, I. Dyrda, S. A. Forman, B. R. Chaitman, B. Sharaf, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study : Improvement of Cardiac Ischemia at 1 Year After PTCA and CABG Circulation, November 1, 1995; 92(9): 1 - 7. [Abstract] [Full Text]